TimesLIVE coverage: Cape Bio Pharms – Cape company turns to tobacco plant in search for Covid-19 antigen

Cape Bio Pharms, a spin-off company of the biopharming research unit at the University of Cape Town, partnered international biotech companies in the Plants Against Corona initiative. The company sourced the gene sequences for SARS-CoV-2 to develop antigen constructs that could speed up production of antigens, globally. To read the full article, click here.